These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 25754631)
1. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma. Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287 [TBL] [Abstract][Full Text] [Related]
4. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. Habra MA; Ejaz S; Feng L; Das P; Deniz F; Grubbs EG; Phan A; Waguespack SG; Ayala-Ramirez M; Jimenez C; Perrier ND; Lee JE; Vassilopoulou-Sellin R J Clin Endocrinol Metab; 2013 Jan; 98(1):192-7. PubMed ID: 23150683 [TBL] [Abstract][Full Text] [Related]
5. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B; J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma. Nelson DW; Chang SC; Bandera BC; Fischer TD; Wollman R; Goldfarb M Ann Surg Oncol; 2018 Jul; 25(7):2060-2066. PubMed ID: 29748889 [TBL] [Abstract][Full Text] [Related]
7. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M; Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma. Wu L; Chen J; Su T; Jiang L; Han Y; Zhang C; Zhou W; Jiang Y; Zhong X; Wang W Front Endocrinol (Lausanne); 2023; 14():1308231. PubMed ID: 38260140 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Sabolch A; Feng M; Griffith K; Hammer G; Doherty G; Ben-Josef E Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1477-84. PubMed ID: 20675074 [TBL] [Abstract][Full Text] [Related]
11. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: Are we offering the best? Srougi V; de Bessa J; Tanno FY; Ferreira AM; Hoff AO; Bezerra JE; Almeida CM; Almeida MQ; Mendonça BB; Nahas WC; Chambô JL; Srougi M; Fragoso MCBV Int Braz J Urol; 2017; 43(5):841-848. PubMed ID: 28727379 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis. Zhu J; Zheng Z; Shen J; Lian X; Miao Z; Shen J; Zhang F Radiat Oncol; 2020 May; 15(1):118. PubMed ID: 32448148 [TBL] [Abstract][Full Text] [Related]
16. Surgical management and clinical prognosis of adrenocortical carcinoma. Dong D; Li H; Yan W; Ji Z; Mao Q Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802 [TBL] [Abstract][Full Text] [Related]
17. Operative intervention for recurrent adrenocortical cancer. Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048 [TBL] [Abstract][Full Text] [Related]
19. Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis. Wu K; Liu X; Liu Z; Lu Y; Wang X; Li X J Natl Compr Canc Netw; 2021 Dec; 19(12):1425-1432. PubMed ID: 34902831 [TBL] [Abstract][Full Text] [Related]
20. Role of radiotherapy in adrenocortical carcinoma. Ho J; Turkbey B; Edgerly M; Alimchandani M; Quezado M; Camphausen K; Fojo T; Kaushal A Cancer J; 2013; 19(4):288-94. PubMed ID: 23867507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]